11.5 C
New York
Wednesday, February 8, 2023

Lufax Holding Ltd (NYSE: LU): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Lufax Holding Ltd (LU) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $2.61. The Lufax Holding Ltd has recorded 69,858 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that LexinFintech Holdings Ltd. Announces Management and Board Changes.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Stocks Info

LU belongs to the Financial sector of the NYSE while operating in the Credit Services industry. At the end of the last regular session, the stock closed at $2.61 and fluctuated between $2.6500 as its day high and $2.4800 as its day low. The current market capitalization of Lufax Holding Ltd is $5.84B. A total of 19.39 million shares were traded on the day, compared to an average of 19.03M shares.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Lufax Holding Ltd pays an annual dividend of $0.17, resulting in a dividend yield of 6.51%, and it has a price to earnings (P/E) ratio of 3.48. LU’s most recent ex-dividend date was 10/12/2022 when it declared a $0.17 quarterly dividend that was paid in cash on 10/28/2022. Previously, the company paid the dividend on 4/15/2022 with an ex-dividend date of 4/7/2022. The LU stock dividend was $0.68 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for LU in the last 3 months, the mean price target is $16.37 with high estimates of $40.66 and low estimates of $9.60. In terms of 52-week highs and lows, LU has a high of $7.05 and a low of $1.26.

As of this writing, LU has an earnings estimate of $0.17 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.19 per share and a lower estimate of $0.14. The company reported an EPS of $0.34 in the last quarter, which was 17.20% higher than expectations of $0.29.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 17 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LU is Underweight with a score of 3.88. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 3 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles